Recent Company News

• 06:53 AM ET Jun 04, 2026
  

  Cloudbreak Pharma completes 12-month final patient visit for phase III clinical trial of CBT-001; to deliver top-line data in Q3 (HK$1.18, 0.00)

• 11:14 PM ET May 24, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (176 total)

• 10:43 PM ET May 20, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (85 total)

• 11:13 PM ET May 19, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (95 total)

• 11:02 PM ET May 12, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 03:06 AM ET May 12, 2026
  

  Santen Pharmaceutical reports Q4 IFRS net income attributable ¥15.56B, +83% vs year-ago ¥8.51B (¥1561.5000, 0)

• 01:59 AM ET Apr 23, 2026
  

  Santen Pharmaceutical releases Sustainability Report 2025 (¥1665.5000, -17.5)

• 11:13 PM ET Apr 07, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (111 total)

• 11:14 PM ET Apr 06, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (58 total)

• 11:01 PM ET Apr 05, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (60 total)